Weaver v. Pfizer, Inc. et al

Filing 24

MDL CONDITIONAL REMAND ORDER by USDC, District of South Carolina. Case remanded and reopened. (Zignago, K.)

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 1 of 5
Case MDL No. 2502 Document 800 Filed 12/09/16 Page 1 of 2

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

FILED
Jan 03, 2017
CLERK, U.S. DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA

MDL No. 2502

(SEE ATTACHED SCHEDULE)

CONDITIONAL REMAND ORDER

The transferee court in this litigation has advised the Panel that coordinated or consolidated pretrial
proceedings in the action(s) on this conditional remand order have been completed and that remand
to the transferor court(s), as provided in 28 U.S.C. § 1407(a), is appropriate.
IT IS THEREFORE ORDERED that the action(s) on this conditional remand order be remanded to
its/their respective transferor court(s).
IT IS ALSO ORDERED that, pursuant to Rule 10.2 of the Rules of Procedure of the United States
Judicial Panel on Multidistrict Litigation, the transmittal of this order to the transferee clerk for
filing shall be stayed 7 days from the date of this order. If any party files a notice of opposition with
the Clerk of the Panel within this 7 day period, the stay will be continued until further order of the
Panel. This order does not become effective until it is filed in the office of the Clerk for the United
States District Court for the District of South Carolina.
IT IS FURTHER ORDERED that, pursuant to Rule 10.4(a), the parties shall furnish the Clerk for
the District of South Carolina with a stipulation or designation of the contents of the record to be
remanded.

Dec 09, 2016

FOR THE PANEL:

Jeffery N. Lüthi
Clerk of the Panel

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 2 of 5
Case MDL No. 2502 Document 800 Filed 12/09/16 Page 2 of 2

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

MDL No. 2502

SCHEDULE FOR CRO
TRANSFEREE
DIST DIV. C.A.NO.
SC 2 14 03235
SC 2 14 03173
SC 2 14 03367
SC 2 14 03592
SC 2 14 03894
SC 2 14 04060

TRANSFEROR
DIST DIV. C.A.NO.
CAC 2 14 03477
CAC 2 14 05792
CAC 2 14 06226
CAC 2 14 06617
CAC 2 14 07432
CAC 2 14 07649

SC

2

14 04384

CAC

2

14 08261

SC
SC
SC

2
2
2

15 02377
14 03232
14 03239

CAC
CAE
CAN

2
2
3

15 01638
14 00818
14 01488

CASE CAPTION
Jewel Williams et al v. Pfizer Inc. et al
Kim Collins et al v. Pfizer Inc. et al
Linda Watson et al v. Pfizer Inc. et al
Helen Elliott et al v. Pfizer Inc. et al
Eliane Scott et al v. Pfizer Inc. et al
Bradley et al v. Pfizer Inc. et al
Granieta Johnson Wilson et al v. Pfizer Inc. et
al
Robyn Whitney et al v. Pfizer Inc. et al
Weaver v. Pfizer, Inc. et al
Stark v. Pfizer et al

2:14-mn-02502-RMG

Date Filed 12/09/16

Entry Number 1776

Page 3 of 5

2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 1 of 3
Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 1 of 3

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 4 of 5
2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 2 of 3
Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 2 of 3

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 5 of 5
2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 3 of 3
Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 3 of 3